The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss.
Eskan MA, Jotwani R, Abe T, Chmelar J, Lim JH, Liang S, Ciero PA, Krauss JL, Li F, Rauner M, Hofbauer LC, Choi EY, Chung KJ, Hashim A, Curtis MA, Chavakis T, Hajishengallis G.
Eskan MA, et al. Among authors: jotwani r.
Nat Immunol. 2012 Mar 25;13(5):465-73. doi: 10.1038/ni.2260.
Nat Immunol. 2012.
PMID: 22447028
Free PMC article.